about
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-61...
Read More
0.77
-0.01
(-1.28%)
309.7K
XNAS Volume
XNAS 16 Oct, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
iBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..